Abstract: The swift advancement of cyber-physical systems (CPSs) across sectors such as healthcare, transportation, critical infrastructure, and energy enhances the crucial requirement for robust ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Abstract: The application of artificial intelligence (AI) requires advanced computation to address complex problems. However, the improvement of binary computing systems supporting these applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback